Microbiota from young mice counteracts selective age-associated behavioral deficits

• Published in: Nature aging Vol. 1; no. 8; pp. 666 - 676
• Main Authors: Boehme, Marcus, Guzzetta, Katherine E, Bastiaanssen, Thomaz F S, van de Wouw, Marcel, Moloney, Gerard M, Gual-Grau, Andreu, Spichak, Simon, Olavarría-Ramírez, Loreto, Fitzgerald, Patrick, Morillas, Enrique, Ritz, Nathaniel L, Jaggar, Minal, Cowan, Caitlin S M, Crispie, Fiona, Donoso, Francisco, Halitzki, Evelyn, Neto, Marta C, Sichetti, Marzia, Golubeva, Anna V, Fitzgerald, Rachel S, Claesson, Marcus J, Cotter, Paul D, O'Leary, Olivia F, Dinan, Timothy G, Cryan, John F
• Format: Journal Article
• Language: English
• Published: United States Nature Publishing Group 01-08-2021
• Subjects: Aging; Cognition & reasoning; Immunity (Disease); Microbiota; Transplants & implants
• ISSN: 2662-8465; 2662-8465
• DOI: 10.1038/s43587-021-00093-9

The gut microbiota is increasingly recognized as an important regulator of host immunity and brain health. The aging process yields dramatic alterations in the microbiota, which is linked to poorer health and frailty in elderly populations. However, there is limited evidence for a mechanistic role of the gut microbiota in brain health and neuroimmunity during aging processes. Therefore, we conducted fecal microbiota transplantation from either young (3-4 months) or old (19-20 months) donor mice into aged recipient mice (19-20 months). Transplant of a microbiota from young donors reversed aging-associated differences in peripheral and brain immunity, as well as the hippocampal metabolome and transcriptome of aging recipient mice. Finally, the young donor-derived microbiota attenuated selective age-associated impairments in cognitive behavior when transplanted into an aged host. Our results reveal that the microbiome may be a suitable therapeutic target to promote healthy aging.